Psychedelics are substances capable of changing perception, mood, and the way a person interprets what is happening inside and outside their head.
We’re not talking about simply “seeing colors” and calling it a day. Psychedelics have been part of rituals, research, medical debates, and conversations for centuries among people trying to understand why the brain can sometimes switch into experimental-cinema mode. In this article, we’ll explain what psychedelics are, what types exist, what effects they can produce, and why science has started taking a closer look at them again.
Psychedelics: What They Are and Why They’re Nothing New
Before getting into the different types of psychedelics, their effects, and therapeutic applications, it’s worth establishing the basics. Because “psychedelic” is often used as a catch-all term, even though not every mind-altering substance works in the same way.
Psychedelics are substances that can alter sensory perception, emotions, thoughts, and a person’s sense of identity. In other words, a psychedelic can change the way you see, feel, remember, or interpret what is happening. Some people describe psychedelic experiences as introspective, spiritual, or revealing; others may experience them as confusing, uncomfortable, or downright distressing.
Interest in psychedelic substances didn’t suddenly appear because of a documentary with deep music. Many cultures have used plants, fungi, and preparations with psychedelic effects in rituals, ceremonies, or spiritual contexts for centuries. Later, during the 20th century, substances such as LSD and psilocybin entered laboratories and psychiatric practices, until legal restrictions put the brakes on a large part of the research.
Now, psychedelics are back on the table. Not because they are magical, but because science is trying to understand whether some of them could help, under medical supervision, with mental health conditions where conventional treatments do not always work.
How Psychedelics Act on the Brain Without Putting on a Lab Coat
The brain doesn’t have a button labeled “trip mode,” but some psychedelics can interact with systems involved in mood, perception, and the way we connect ideas.
Many classic psychedelics act on systems related to serotonin, a molecule involved in mood, perception, and certain emotional processes. It is commonly referred to as the “happiness hormone.” Specifically, substances such as psilocybin, LSD, mescaline, and DMT interact with brain receptors that can temporarily alter the way the brain organizes information.
This doesn’t mean they “reset the mind” as if they were the brain’s equivalent of a router’s on/off button. It’s a catchy phrase for social media, but it’s far too simplistic. What does seem clear is that psychedelics can temporarily alter the way ideas, memories, emotions, and sensory stimuli connect with one another over the course of several hours.
The Famous “Set and Setting”
If there’s one key idea to understand when talking about psychedelics without making a fool of yourself, it’s this: the experience does not depend solely on the substance. A person’s mental state and their surroundings also have a major influence.
In Psychedelics 101, this is known as “set and setting.” The “set” refers to a person’s internal state: their mood, fears, expectations, and emotional situation. The “setting” is the place, the people around them, the atmosphere, and how safe the environment feels. The same psychedelic substance can feel very different in a calm environment compared with a chaotic setting filled with noise, pressure, or people you don’t trust.
Interactive Set and Setting Explorer: The 5 Key Factors That Shape a Psychedelic Experience
Set and Setting
Click on each factor to explore how it influences the experience
Types of Psychedelics and Related Substances
When people talk about psychedelic drugs, they often lump everything into the same category. Rookie mistake. LSD is not the same as MDMA, and psilocybin is not the same as ketamine. Some substances are classic psychedelics, while others are empathogens or dissociatives, and each group has its own story to tell.
Classic Psychedelics
Classic psychedelics are the substances most commonly associated with the traditional psychedelic experience. This group includes substances such as LSD, psilocybin, mescaline, and DMT.
Psilocybin is the compound found in some hallucinogenic mushrooms and magic truffles. LSD is a semisynthetic substance known for its powerful and long-lasting effects. Mescaline occurs in certain cacti, such as peyote and San Pedro. DMT, meanwhile, is found in some plants and is also associated with traditional preparations such as ayahuasca.
These psychedelics can cause visual alterations, changes in the perception of time, more associative thinking, deep introspection, and experiences that some people interpret as mystical or spiritual.
Empathogens: The Case of MDMA
MDMA often comes up in conversations about psychedelics, but there is an important distinction to make: it is not a classic psychedelic. It is generally considered an empathogen or entactogen because its effects are often associated with emotional openness, increased empathy, interpersonal connection, and a temporary reduction in fear in certain contexts.
For this reason, this psychedelic drug has been studied in assisted therapy for post-traumatic stress disorder. But there is a big difference between something being researched and saying that it is already an approved solution ready for everyone.
MDMA can also carry significant physical risks, including increased body temperature, blood pressure changes, dehydration, overhydration from drinking excessive amounts of water, jaw tension, and interactions with medications.
Dissociatives: Ketamine and Beyond
Ketamine also works differently from classic psychedelics. It is considered a dissociative because it can cause a sense of separation from the body, the environment, or one’s own identity. In medical settings, it is used as an anesthetic and, in specific forms such as esketamine, is also used in some countries for treatment-resistant depression under professional supervision.
Here, the distinction is important: controlled clinical use of psychedelics is one thing, while using them outside a healthcare setting is something entirely different. A supervised treatment plan is not the same as jumping into the mud without a map.
Interactive comparison of psychedelic types: classic psychedelics, empathogens, and dissociatives
Types of psychedelics
Select each category to learn about their differences
Effects of Psychedelics: The Beautiful, the Strange, and What Can Go Wrong
The effects of psychedelics don’t come in a set daily menu. It’s not “you take this and exactly that happens.” They depend on the substance, the person, the moment, the environment, the amount, and whether the brain decides to switch on neon lights or open emotional drawers that have been taped shut for years.
Some of the best-known effects of psychedelics include visual alterations, intensified colors, moving patterns, changes in the perception of sound, the sensation that time is moving slower or faster, and a less linear way of thinking.
Introspection, intense memories, feelings of connection, amplified emotions, or experiences that are difficult to explain in ordinary words can also occur. Some people describe them as a “trip,” “expanded consciousness,” or a “mystical experience.” Others simply say: “I don’t know what just happened, but that was too much.”
Physical Effects of Psychedelics That Shouldn’t Be Ignored
Although people often focus on the mental side, psychedelics can also have physical effects. Depending on the substance, nausea, sweating, dilated pupils, muscle tension, changes in heart rate, post-experience fatigue, or difficulty sleeping may occur.
With substances such as MDMA, the physical risks associated with psychedelic-related drug use can be more pronounced, especially in hot environments, during intense dancing, when there is insufficient rest, or when other substances are involved. With ketamine, the risk of disorientation, falls, or losing awareness of the surroundings is also something to take seriously.
Bad Trips: When the Brain Gets Too Creative on Psychedelics
A bad trip on psychedelics is not a joke or a funny story to tell in a mysterious voice. It can be a highly distressing experience involving intense fear, paranoia, confusion, a sense of losing control, or thoughts that are difficult to manage.
People with a history of psychosis, bipolar disorder, severe anxiety, serious mental health conditions, or psychiatric medication should exercise particular caution. In these cases, speaking with a healthcare professional isn’t responsible posturing: it’s basic common sense.
Psychedelics and Mental Health: What Is Actually Being Researched?
This is where the internet often switches into guru mode with a mystical robe. “Psilocybin cures depression,” “MDMA eliminates trauma,” “ketamine resets the brain.” It sounds powerful, sure. But it also sounds far too good to repeat without some important context.
The reality is more interesting and more cautious. Some psychedelics are being studied in clinical settings for conditions such as treatment-resistant depression, anxiety associated with serious illness, addiction, or post-traumatic stress disorder. But these studies are not simply about taking a substance and waiting for miracles. They usually involve preparation, professional support, a controlled environment, and integration sessions afterward.
Interactive Map of Therapeutic Research into Psychedelics: Psilocybin, MDMA, Ketamine, LSD, and DMT
Therapeutic Research Status
Click on each substance to see the details. This does not mean it is an approved treatment for general use.
⚠️ This content is for informational purposes only. The fact that a substance is being studied in clinical research does not mean it is legal for personal use or that it can be used without medical supervision.
Psilocybin is one of the most studied substances among classic psychedelics. It is being researched for its potential usefulness in depression, anxiety, and addiction, including how it acts on the brain, although it should not yet be presented as a generally approved treatment.
MDMA has been studied alongside psychotherapy for Post-Traumatic Stress Disorder (PTSD), but its regulatory path has faced significant obstacles. This shows that the subject is promising, yes, but also complex.
Ketamine and esketamine occupy another place in this conversation. They are not classic psychedelics, but they are frequently mentioned because of their connection to treatments for treatment-resistant depression. In certain medical settings, esketamine is used under clinical supervision, following specific protocols and professional monitoring.
Risks of Psychedelics
Psychedelics may be trendy, but being trendy does not make the risks disappear. And if someone tells you that it is all about healing, universal love, and mental rainbows, be suspicious. They may just be showing you the pretty side of the poster.
The main psychological risks include intense anxiety, panic, paranoia, confusion, disorientation, emotionally overwhelming experiences, and possible worsening of symptoms in vulnerable people. Difficult memories or emotions may also suddenly surface, without asking permission or knocking on the door.
Polydrug use is another sensitive issue. Combining psychedelics with alcohol, cannabis, stimulants, antidepressants, or other medications can make the experience more unpredictable or increase physical and psychological risks. In particular, when medication is involved, consulting a healthcare professional is essential.
There is also the legal side of things. The legal status of psychedelic drugs varies depending on the country, substance, and context. Some may be permitted for research, specific medical use, or traditional ceremonies in certain places, but that does not mean they can be freely purchased or consumed. Checking local legislation is essential.
So why are psychedelic substances attracting so much interest now?
Because mental health is at the center of the conversation, and current treatments do not work equally well for everyone.
There is more scientific research, more documentaries, more books, more podcasts, and more social curiosity. There is also a genuine need to find new tools for complex problems such as treatment-resistant depression, trauma, or addiction. But that curiosity comes with a lot of noise: exaggerated headlines, internet gurus, miracle promises, and people who confuse an intense experience with therapy.
That is why we need to talk about psychedelic drugs with both hands on the wheel. Neither demonize them as if they were from a horror movie, nor sell them as if they were the secret shortcut to eternal happiness.
They are complex substances, with a long history, powerful effects, real risks, and therapeutic potential that is still being investigated. They can alter perception, trigger intense emotional processes, and temporarily change the way a person interprets their internal and external world.
But not all psychedelic drugs are the same. Psilocybin is not the same as MDMA, nor is LSD the same as ketamine. A clinical study involving professionals is also very different from an improvised experience without information, a safe environment, or an understanding of the risks.
At SmartshopLove, we share this content for informational and educational purposes. We do not promote the use of psychedelic drugs or recommend their use to treat mental health problems. If there is severe anxiety, psychiatric medication, a history of psychosis, bipolar disorder, or any other relevant medical condition, the responsible approach is to speak with a healthcare professional.
Curiosity is fine. Information is better. Getting carried away without the facts, well, that is a whole different movie.